Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04239573 · ClinicalTrials.gov registry record · NA
Comparing Two Methods to Follow Patients With Pancreatic Cysts
A NA study of Pancreatic Carcinoma, sponsored by ECOG-ACRIN Cancer Research Group.
- Active
- Registry status
- NA
- Development phase
- 4,606
- Enrollment target
- 20
- Study locations
NCT04239573 is a NA study of Pancreatic Carcinoma that is active but no longer recruiting, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 4,606 participants, above the 3,229-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (43% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT04239573, a NA study of Pancreatic Carcinoma, is active but no longer recruiting, sponsored by ECOG-ACRIN Cancer Research Group.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 4,606 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to compare the two approaches for monitoring pancreatic cysts. The study doctors want to compare more frequent monitoring vs less frequent monitoring in order to learn which monitoring method leads to better outcome for patients with pancreatic cysts.
Conditions Studied
Interventions
- PROCEDURE Computed Tomography
- OTHER Quality-of-Life Assessment
- PROCEDURE Magnetic Resonance Imaging
- OTHER Questionnaire Administration
- PROCEDURE Endoscopic Ultrasound
Study Locations (20)
Alaska
- Anchorage Associates in Radiation Medicine - Anchorage
- Anchorage Radiation Therapy Center - Anchorage
- Alaska Breast Care and Surgery LLC - Anchorage
- Alaska Oncology and Hematology LLC - Anchorage
- Alaska Women's Cancer Care - Anchorage
- Anchorage Oncology Centre - Anchorage
- Katmai Oncology Group - Anchorage
- Providence Alaska Medical Center - Anchorage
California
- Providence Saint Joseph Medical Center/Disney Family Cancer Center - Burbank
- Enloe Medical Center - Chico
- UC San Diego Health System - Encinitas - Encinitas
- UC San Diego Moores Cancer Center - La Jolla
- Loma Linda University Medical Center - Loma Linda
- Veterans Affairs Loma Linda Healthcare System - Loma Linda
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
- University of South Alabama Mitchell Cancer Institute - Mobile
Arizona
- Mayo Clinic Hospital in Arizona - Phoenix
- Mayo Clinic in Arizona - Scottsdale
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,606 participants |
| Start Date | 2020-06-16 |
| Est. Completion | 2037-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04239573
The ClinicalTrials.gov registry entry for NCT04239573 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 4,606 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,229-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (43% higher). The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Computed Tomography is the first listed.
NCT04239573 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Alaska, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT04239573 about?
NCT04239573 is a clinical study titled "Comparing Two Methods to Follow Patients With Pancreatic Cysts". The purpose of this study is to compare the two approaches for monitoring pancreatic cysts. The study doctors want to compare more frequent monitoring vs less frequent monitoring in order to learn which monitoring method leads to better outcome for patients with pancreatic cysts.
What is the current status of trial NCT04239573?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 4,606 participants. The study started on 2020-06-16. Estimated completion is 2037-06-03.
What conditions does trial NCT04239573 study?
This clinical trial studies the following conditions: Pancreatic Carcinoma.
What interventions are being tested in trial NCT04239573?
The interventions under investigation include: Computed Tomography (PROCEDURE), Quality-of-Life Assessment (OTHER), Magnetic Resonance Imaging (PROCEDURE), Questionnaire Administration (OTHER), Endoscopic Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT04239573?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04239573 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
RECRUITING · NA
-
The Vanguard Study: Testing a New Way to Screen for Cancer
RECRUITING · NA
-
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
ACTIVE NOT RECRUITING · NA
-
The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer
COMPLETED · NA
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
COMPLETED · NA
-
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.